Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

University of Ottawa

$10,000.00

The University of Ottawa Fear of Cancer Recurrence International Colloquium

FY 2014-15

Summary
BACKGROUND: Fear of cancer recurrence (FCR) has been described as the sword of Damocles that hangs over patients for the rest of their lives. While there is a wide variability in patients' severity of their FCR, research has shown that severe FCR tends to persist over time. The current literature suggests that moderate to high levels of FCR, suggestive of clinical FCR, affect 49% of cancer patients. There is also clear evidence that FCR is associated with psychological distress and increased medical costs. PURPOSE OF THE COLLOQUIUM: Despite this, there are many gaps in our current knowledge of FCR. There is no consensus on the definition of FCR or on the characteristics of clinical FCR (i.e. at what point is this fear no longer a "normal concern". To date, there are no guidelines available for health care professionals about screening for FCR among cancer survivors. Also, there are several interventions currently being tested, and we need to examine what ingredients they have in common to make recommendations about the best way to treat clinical FCR. METHODS: In order to answer these questions, we propose to organize a two-day colloquium at the University of Ottawa on August 3 and 4, 2015. This colloquium bring together 17 researchers who are experts in the field, 1 Policy maker who is a cancer survivorship expert, and 2 patient advocates. Several Ph.D. level students will be involved and will have opportunities to present their research findings. EXPECTED OUTPUT: At the end of the colloquium, we will produce a report (target audience: general community and policy makers) and a scientific paper (target audience: clinicians and researchers) that will make recommendations about future research directions and best practice for screening and intervention for survivors dealing with high FCR based on current evidence.
Program
Planning and Dissemination Grant - Institute Community Support
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
325072
Name
Lebel Sophie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Planning and Dissemination - ICR
Projecttitle
The University of Ottawa Fear of Cancer Recurrence International Colloquium
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Ottawa
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Best Practice; Cancer; Colloquium; Consensus; Fear Of Cancer Recurrence; International; Intervention; Knowledge Transfer; Screening; Survivorship
Abstract
BACKGROUND: Fear of cancer recurrence (FCR) has been described as the sword of Damocles that hangs over patients for the rest of their lives. While there is a wide variability in patients' severity of their FCR, research has shown that severe FCR tends to persist over time. The current literature suggests that moderate to high levels of FCR, suggestive of clinical FCR, affect 49% of cancer patients. There is also clear evidence that FCR is associated with psychological distress and increased medical costs. PURPOSE OF THE COLLOQUIUM: Despite this, there are many gaps in our current knowledge of FCR. There is no consensus on the definition of FCR or on the characteristics of clinical FCR (i.e. at what point is this fear no longer a "normal concern". To date, there are no guidelines available for health care professionals about screening for FCR among cancer survivors. Also, there are several interventions currently being tested, and we need to examine what ingredients they have in common to make recommendations about the best way to treat clinical FCR. METHODS: In order to answer these questions, we propose to organize a two-day colloquium at the University of Ottawa on August 3 and 4, 2015. This colloquium bring together 17 researchers who are experts in the field, 1 Policy maker who is a cancer survivorship expert, and 2 patient advocates. Several Ph.D. level students will be involved and will have opportunities to present their research findings. EXPECTED OUTPUT: At the end of the colloquium, we will produce a report (target audience: general community and policy makers) and a scientific paper (target audience: clinicians and researchers) that will make recommendations about future research directions and best practice for screening and intervention for survivors dealing with high FCR based on current evidence.
Competitiondate
201502
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lebel, Sophie
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $10,000~ $0~